Scancell Holdings plc (SCLP) Ord GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
14.50p
15.00p
19.50p
£134.79 million
14.50p
14.50p
8.70p
n/a
0.50p (3.33%) Previous:
0.50p
10,005
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 30/04/2024 | 30/04/2023 |
---|---|---|
Revenue (£m) | n/a | 5.27 |
Profit before tax (£m) | (9.12) | (14.30) |
Adjusted EPS (p): | (0.68) | (1.50) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Scancell shares jump on new antibody agreement with major biotech firm
12 June 2024 07:53
-
Scancell appoints healthcare finance veteran as new CFO
29 August 2023 14:27
-
Scancell to present positive recent findings at oncology summit
2 June 2023 13:18
-
Positive data from Phase 2 SCOPE trial with SCIB1
18 November 2024 07:00
-
Result of Annual General Meeting
25 October 2024 15:26
-
Holding(s) in Company
24 October 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.